Growing community of inventors

Flemington, NJ, United States of America

John Krupinski

Average Co-Inventor Count = 8.00

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 44

John KrupinskiDasa Lipovsek (6 patents)John KrupinskiRay Camphausen (6 patents)John KrupinskiPaul E Morin (6 patents)John KrupinskiDaniel Cohen (6 patents)John KrupinskiRanjan Mukherjee (6 patents)John KrupinskiRose C Christian (6 patents)John KrupinskiTimothy Patrick Reilly (6 patents)John KrupinskiJohn Krupinski (6 patents)Dasa LipovsekDasa Lipovsek (53 patents)Ray CamphausenRay Camphausen (45 patents)Paul E MorinPaul E Morin (22 patents)Daniel CohenDaniel Cohen (13 patents)Ranjan MukherjeeRanjan Mukherjee (10 patents)Rose C ChristianRose C Christian (7 patents)Timothy Patrick ReillyTimothy Patrick Reilly (7 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bristol-myers Squibb Compnay (6 from 3,681 patents)


6 patents:

1. 12247058 - Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof

2. 11248031 - Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides

3. 10377806 - Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof

4. 10189883 - Therapeutic uses of modified FGF-21 polypeptides

5. 9631004 - Modified FGF-21 polypeptides comprising an internal deletion and uses thereof

6. 9434778 - Modified FGF-21 polypeptides comprising an internal deletion and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…